Subclinical
oral
human
papillomavirus
(
HPV
)
infection
persists
decades
likely
precede
HPV-driven
squamous
cell
carcinoma
head
neck
,
little
known
natural
history
oral
HPV
.

We
systematically
reviewed
abstracted
data
nine
manuscripts
examined
human
immunodeficiency
virus-negative
cancer-free
subjects
oral
HPV
DNA
determine
pooled
baseline
prevalence
incidence
newly
acquired
oral
HPV
infections
,
specifically
HPV-16
.

We
also
documented
clearance
rate
median
time
clearance
,
data
existed
.

Of
3762
individuals
,
7.5
%
oral
infection
HPV
type
(
1.6
%
HPV-16
)
.

Meta-regression
analysis
estimated
12-month
cumulative
incidence
4.8
%
(
95
%
confidence
interval
3.2-7.3
%
)
.

The
overall
oral
HPV
clearance
reported
0-80
%
studies
,
median
time
clearance
6.5
18
months
.

Oral
HPV-16
clearance
43-83
%
,
median
time
clearance
HPV-16
7-22
months
.

Oral
HPV
prevalence
,
incidence
clearance
vary
considerably
published
studies
different
geographical
regions
.

Further
research
required
identify
predictors
persistent
oral
HPV
infection
.

Measurable
baseline
prevalence
observed
studies
,
well
non-trivial
incidence
newly
acquired
oral
HPV
infections
incomplete
clearance
.

